Sensus Healthcare (SRTS) Research & Development (2016 - 2025)

Sensus Healthcare's Research & Development history runs 10 years deep, the most recent figure standing at $1.9 million for Q4 2025.

• On a quarterly basis, Research & Development rose 20.56% year-over-year to $1.9 million in Q4 2025; TTM through Dec 2025 was $7.0 million, a 39.89% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, up 84.49% from the prior year.
• Research & Development improved to $1.9 million in Q4 2025 per SRTS's latest filing, from $1.5 million in the prior quarter.
• Across five years, Research & Development topped out at $2.5 million in Q4 2021 and bottomed at $677000.0 in Q4 2023.
• The 5-year median for Research & Development is $1.3 million (2023), against an average of $1.4 million.
• Across the five-year window, Research & Development surged 1366.67% in 2021 and slumped 53.83% in 2022, its largest moves.
• Year by year, Research & Development stood at $2.5 million in 2021, then slumped by 53.83% to $1.2 million in 2022, then plunged by 41.54% to $677000.0 in 2023, then surged by 130.58% to $1.6 million in 2024, then increased by 20.56% to $1.9 million in 2025.
• Per Business Quant, the three latest SRTS Research & Development figures stand at $1.9 million (Q4 2025), $1.5 million (Q3 2025), and $1.4 million (Q2 2025).